Soleus Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Soleus Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$106M	Sell	330,517 -32,449	-9%	-$10M	4.31%	7
2025 Q4	$107M	Sell	362,966 -496,200	-58%	-$92.4M	3.95%	5
2025 Q3	$45.5M	Sell	859,166 -107,574	-11%	-$5.22M	2.29%	16
2025 Q2	$40.7M	Sell	966,740 -173,000	-15%	-$6.59M	2.69%	11
2025 Q1	$43.2M	Buy	1,139,740 +896,200	+368%	+$56M	3.11%	10
2024 Q4	$18.7M	Sell	243,540 -15,858	-6%	-$1.15M	1.18%	26
2024 Q3	$14.9M	Sell	259,398 -273,617	-51%	-$14.8M	1.16%	33
2024 Q2	$22M	Buy	533,015 +495,747	+1,330%	+$23.4M	1.94%	17
2024 Q1	$2.27M	Buy	+37,268	New	+$1.67M	0.17%	75
2023 Q4	–	Sell	-76,667	Closed	-$1.97M	–	98
2023 Q3	$1.97M	Sell	76,667 -63,333	-45%	-$1.2M	0.18%	69
2023 Q2	$2.42M	Buy	+140,000	New	+$2.14M	0.27%	69

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Soleus Capital Management's PRAX Position: Q1 2026 in Review

Soleus Capital Management reduced its Praxis Precision Medicines (PRAX) stake by 8.9% in Q1 2026, selling an estimated $10M and leaving 330,517 shares worth $106M. The position accounts for 4.31% of the portfolio, ranked #7.

Soleus Capital Management first reported a position in PRAX in Q2 2023 and has held it in 11 quarters since. The position peaked at $107M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Soleus Capital Management held 330,517 shares of Praxis Precision Medicines worth $106M as of Q1 2026.
Soleus Capital Management sold 32,449 Praxis Precision Medicines shares in Q1 2026, an estimated $10M.
Praxis Precision Medicines made up 4.31% of Soleus Capital Management's portfolio in Q1 2026, its #7 holding.
Soleus Capital Management first reported a position in Praxis Precision Medicines in Q2 2023 and has held it in 11 quarters since.
Soleus Capital Management's Praxis Precision Medicines position peaked at $107M in Q4 2025.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.